Stenabolic Sarms Raw Powder SR9009 Raw White Crystalline Powder CAS 1379686-30-2

A New Drug Known As SR9009, Which Is Presently Under Development At TSRI (The Scripps Research Institute) Has Been Shown To Considerably Boost Exercise Endurance In Animal Models. Scientists Think These Discoveries May Lead To Improved Cures For Individuals Suffering From Illnesses That Severely Limit Exercise Endurance Such As Obesity, COPD (Chronic Obstructive Pulmonary Disease), Congestive Heart Failure And Also In The Deterioration Of Muscle Capacity Linked With Aging.

The Drug Was Developed By Professor Thomas Burris Who Found That It Was Capable Of Reducing Obesity In Animal Models, Particularly Mice. SR9009 Which Is An Easy To Dose Oral Compound Can Increase The Level Of Metabolic Activity In Skeletal Muscle Of Mice. The Treated Mice Became Lean, Developed Larger Muscles And Had A 50% Increase In Running Abilities Which Imitates The Effects Of Aerobic Exercise.